Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer have?
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer has 122 citations in the OpenAlex counts ScholarIQ stores.
When was Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer published?
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer has 2013 year in the ScholarIQ index.
What is the open-access status of Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer?
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer has green oa status in the ScholarIQ index.
What is the DOI of Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer?
The DOI for Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer is on the source record.
What is the PMID of Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer?
The PMID for Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer is on the source record.
What is the OpenAlex record for Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer?
The OpenAlex for Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer is on the source record.